Reading this on a mobile device? Try our optimized mobile version here:

June 16, 2009
FreeMind Group, a firm specializing in identifying and raising funds from government agencies through grants and contracts, is BIO's newest strategic partner under the BIO Business Solutions cost-saving program. BIO members receive 20% off FreeMind Group's upfront fees.

The news summaries appearing in BIO SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The information is not compiled or summarized by BIO. Questions and comments should be directed to SmartBrief at

  Today's Top Story 
  • Medicare advisers call for legal pathway for follow-on biologics
    The Medicare Payment Advisory Commission called on Congress to cut Medicare costs by reviewing the reimbursement rates for imaging scans, by providing a pathway that would enable the FDA to approve follow-on biologics and by reducing payments to private insurance plans. The recommendations come after President Barack Obama proposed to save $313 billion in Medicare spending to help support his $1 trillion health reform program. Reuters (6/15) LinkedInFacebookTwitterEmail this Story
  Health Care & Policy 
  • 2 senators work to block comparative-effectiveness bill
    Sens. Jon Kyl, R-Ariz., and Mitch McConnell, R-Ky., introduced a bill that would block President Barack Obama's proposal to conduct comparative-effectiveness research on drugs, medical devices and other treatments. Kyl argued that the research would lead to rationed health care, eventually delaying treatment and weakening the quality of care. Politico (Washington, D.C.) (6/15) LinkedInFacebookTwitterEmail this Story
  • Scientists find clue to chronic asthma
    U.K. researchers found that a cellular pump in airway muscle cells called SERCA2 plays a key role in the development of chronic asthma. The researchers say they hope the finding could lead to more effective ways of controlling asthma symptoms. BBC (6/15) LinkedInFacebookTwitterEmail this Story
  Company & Financial News 
  • Lilly rolls out Web portal for promising compounds
    Eli Lilly and Co. launched a Web portal that contains ideas and other data from academic researchers and biotech companies on potential and experimental compounds. The Lilly Phenotypic Drug Discovery Initiative allows the company to evaluate and possibly license treatments "that are never fully evaluated as potential drug candidates," a Lilly official said. Indianapolis Business Journal (6/15) LinkedInFacebookTwitterEmail this Story
  • Other News
  Global Developments 

Interested in learning more about advertising in BIO SmartBrief? Contact Meryl Harold at (202) 407-7828 or 

  Featured Content 

  Food & Agriculture 
  Industrial & Environmental 
  • Biofuel producers upbeat on meeting government mandates
    Biofuel companies are optimistic that they will be able to meet the federal mandates on biofuel production by using a variety of existing and emerging technologies. These technologies include Edenspace Systems' Energy Corn, a feedstock that aims to cut the cost of producing cellulosic biofuels, and Coskata's Flex Ethanol technology, a hybrid approach to producing fuel-grade ethanol. Genetic Engineering & Biotechnology News (6/15) LinkedInFacebookTwitterEmail this Story
  News from BIO 
  • Feeling the pinch in today's market hurts
    Let BIO ease your pain with BIO Business Solutions, BIO's cost-savings program, which provides products and services specific to the life sciences industry at discounted prices and other benefits. Participation is free to members of BIO and 38 state/regional biotech associations, and more than 1,900 companies currently use BIO Business Solutions. See how BIO Business Solutions can help your bottom line. Get more information about the 15 money-saving opportunities here. LinkedInFacebookTwitterEmail this Story
Learn more about BIO ->Conferences  |  Join BIO  |  Media  |  Issues  |  Industry

Life is like a box of chocolates. You never know what you're going to get."
--Tom Hanks,
American actor, in "Forrest Gump"

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Executive:  Meryl Harold (202) 407-7828
A powerful website for SmartBrief readers including:
 Recent BIO SmartBrief Issues:   Lead Editor:  Ashley McMaster
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005
© 1999-2011 SmartBrief, Inc.® Legal Information